Martin Vogelhuber Selected Research

Martin Vogelhuber Research Topics

Disease

10	Neoplasms (Cancer) 10/2023 - 08/2015
8	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 05/2010
3	Disease Progression 01/2021 - 01/2018
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2022 - 08/2015
2	Polyneuropathies (Polyneuropathy) 01/2021 - 01/2018
2	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 01/2016
2	Multiple Myeloma 01/2019 - 08/2015
2	Poisoning 11/2018 - 01/2018
1	Glioma (Gliomas) 10/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Mucositis 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Microsatellite Instability 01/2021
1	Deglutition Disorders (Dysphagia) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Myasthenia Gravis 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2020
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Thromboembolism 01/2019
1	Fever (Fevers) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Neutropenia 01/2018
1	Diarrhea 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016
1	Carcinoma (Carcinomatosis) 08/2015
1	Prostatic Neoplasms (Prostate Cancer) 08/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2015
1	Anemia 05/2010
1	Fatigue 05/2010
1	Paraproteinemias (Monoclonal Gammopathy) 07/2002

Drug/Important Bio-Agent (IBA)

5	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2020 - 04/2015
3	Dacarbazine (DIC)FDA LinkGeneric 11/2019 - 04/2015
3	Vinblastine (Vinblastine Sulfate)FDA Link 11/2019 - 04/2015
2	PlatinumIBA 01/2021 - 02/2020
2	NivolumabIBA 01/2021 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2020 - 10/2018
2	Vincristine (Oncovin)FDA LinkGeneric 02/2020 - 10/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2019 - 04/2015
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 01/2019
2	Rituximab (Mabthera)FDA Link 01/2019 - 10/2018
2	Dasatinib (BMS 354825)FDA Link 01/2019 - 01/2016
2	Immunomodulating AgentsIBA 11/2018 - 01/2018
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2018 - 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023
1	Docetaxel (Taxotere)FDA Link 01/2021
1	IpilimumabIBA 01/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	treosulfanIBA 01/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	Gemcitabine FDA Link 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 02/2020
1	Epirubicin (Ellence)FDA LinkGeneric 02/2020
1	CrizotinibIBA 01/2020
1	AnthracyclinesIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2018
1	ThiazolidinedionesIBA 11/2018
1	trofosfamideIBA 10/2018
1	Prednisone (Sone)FDA LinkGeneric 10/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Drug CombinationsIBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Leucovorin (Folinic Acid)FDA Link 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Epoetin Alfa (Epogen)FDA Link 05/2010
1	AutoantibodiesIBA 07/2002

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2023 - 05/2010
11	Therapeutics 12/2022 - 08/2015
3	Radiotherapy 10/2023 - 11/2019
1	Immunotherapy 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Combined Modality Therapy 01/2021
1	Palliative Care (Palliative Therapy) 11/2018
1	Combination Drug Therapy (Combination Chemotherapy) 10/2018
1	Drug Tapering 01/2018
1	Castration 08/2015